Susana Gonzalez

Susana Gonzalez

Auto-generated profile, based on publicly available information

Susana Gonzalez

Stem Cell Aging Group, Spanish National Cardiovascular Research Center (CNIC), Madrid, Spain

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2011 in Nature Communications
Verified
Journal Article
Open access
PDF file
MMMaria Mittelbrunn
Maria Mittelbrunn
CGCristina Gutiérrez-Vázquez
Cristina Gutiérrez-Vázquez
CVCarolina Villarroya-Beltri
Carolina Villarroya-Beltri
SGSusana González
Susana González
FSFatima Sanchez-Cabo
Fatima Sanchez-Cabo
FSFrancisco Sánchez-Madrid
Francisco Sánchez-Madrid
The immune synapse is an exquisitely evolved means of communication between T cells and antigen-presenting cells (APCs) during antigen recognition. Recent evidence points to the transfer of RNA via exosomes as a novel mode of intercellular communication. Here we show that exosomes of T, B and dendritic immune cells contain microRNA (miRNA) repertoires that differ from those of their parent cells. We investigate whether miRNAs are exchanged during cognate immune interactions, and demonstrate the existence of antigen-driven unidirectional transfer of miRNAs from the T cell to the APC, mediated by the delivery of CD63+ exosomes on immune synapse formation. Inhibition of exosome production by targeting neutral sphingomyelinase-2 impairs transfer of miRNAs to APCs. Moreover, miRNAs transferred during immune synapsis are able to modulate gene expression in recipient cells. Thus, our results support a mechanism of cellular communication involving antigen-dependent, unidirectional intercellular transfer of miRNAs by exosomes during immune synapsis.

12 February 2014 in Nature
Verified
Journal Article
Closed access
PSPedro Sousa-Victor
Pedro Sousa-Victor
SGSusana Gutarra
Susana Gutarra
LGLaura García-Prat
Laura García-Prat
JRJavier Rodriguez-Ubreva
Javier Rodriguez-Ubreva
LOLaura Ortet
Laura Ortet
PMPura Muñoz-Cánoves
Pura Muñoz-Cánoves

1 November 2012 in Cell Stem Cell
Verified
Journal Article
Closed access
IHIsabel Hidalgo
Isabel Hidalgo
AHAntonio Herrera-Merchan
Antonio Herrera-Merchan
JLJose Manuel Ligos
Jose Manuel Ligos
LCLaura Carramolino
Laura Carramolino
JNJavier Nuñez
Javier Nuñez
SGSusana Gonzalez
Susana Gonzalez

1 September 2008 in Journal of Experimental Medicine
Verified
Journal Article
Open access
VYVirginia G. de YébEnes
Virginia G. de YébEnes
LBLaura Belver
Laura Belver
DPDavid G. Pisano
David G. Pisano
SGSusana GonzálEz
Susana GonzálEz
Aranzazu VillasanteAranzazu Villasante
Aranzazu Villasante
ARAlmudena R. Ramiro
Almudena R. Ramiro
Activated B cells reshape their primary antibody repertoire after antigen encounter by two molecular mechanisms: somatic hypermutation (SHM) and class switch recombination (CSR). SHM and CSR are initiated by activation-induced cytidine deaminase (AID) through the deamination of cytosine residues on the immunoglobulin loci, which leads to the generation of DNA mutations or double-strand break intermediates. As a bystander effect, endogenous AID levels can also promote the generation of chromosome translocations, suggesting that the fine tuning of AID expression may be critical to restrict B cell lymphomagenesis. To determine whether microRNAs (miRNAs) play a role in the regulation of AID expression, we performed a functional screening of an miRNA library and identified miRNAs that regulate CSR. One such miRNA, miR-181b, impairs CSR when expressed in activated B cells, and results in the down-regulation of AID mRNA and protein levels. We found that the AID 3′ untranslated region contains multiple putative binding sequences for miR-181b and that these sequences can be directly targeted by miR-181b. Overall, our results provide evidence for a new regulatory mechanism that restricts AID activity and can therefore be relevant to prevent B cell malignant transformation.

29 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ABAna Filipa Roque Branco
Ana Filipa Roque Branco
Susana P. PereiraSusana P. Pereira
Susana P. Pereira
SGSusana Gonzalez
Susana Gonzalez
OGOleg Gusev
Oleg Gusev
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov
POPaulo Oliveira
Paulo Oliveira
H9c2 myoblasts are a cell model used as an alternative for cardiomyocytes. H9c2 cells have the ability to differentiate towards a cardiac phenotype when the media serum is reduced in the presence of all-trans-retinoic acid (RA), creating multinucleated cells with low proliferative capacity. In the present study, we performed for the first time a transcriptional analysis of the H9c2 cell line in two differentiation states, i.e. embryonic cells and differentiated cardiac-like cells. The results show that RA-induced H9c2 differentiation increased the expression of genes encoding for cardiac sarcomeric proteins such as troponin T, or calcium transporters and associated machinery, including SERCA2, ryanodine receptor and phospholamban as well as genes associated with mitochondrial energy production including respiratory chain complexes subunits, mitochondrial creatine kinase, carnitine palmitoyltransferase I and uncoupling proteins. Undifferentiated myoblasts showed increased gene expression of pro-survival proteins such as Bcl-2 as well as cell cycle-regulating proteins. The results indicate that the differentiation of H9c2 cells lead to an increase of transcripts and protein levels involved in calcium handling, glycolytic and mitochondrial metabolism, confirming that H9c2 cell differentiation induced by RA towards a more cardiac-like phenotype involves remodeled mitochondrial function. PI3K, PDK1 and p-CREB also appear to be involved on H9c2 differentiation. Furthermore, complex analysis of differently expressed transcripts revealed significant up-regulation of gene expression related to cardiac muscle contraction, dilated cardiomyopathy and other pathways specific for the cardiac tissue. Metabolic and gene expression remodeling impacts cell responses to different stimuli and determine how these cells are used for biochemical assays.

30 March 2006 in Nature
Verified
Journal Article
Closed access
PDF file
SGSusana Gonzalez
Susana Gonzalez
PKPeter Klatt
Peter Klatt
SDSonia Delgado
Sonia Delgado
ECEsther Conde
Esther Conde
FLFernando Lopez-Rios
Fernando Lopez-Rios
MSManuel Serrano
Manuel Serrano